...June 1, 2026 TORONTO (S&P Global Ratings) June 1, 2026--S&P Global Ratings today assigned its `###-' issue- level rating and `2' recovery rating to U.S.-based medical device manufacturer Teleflex Inc.'s new $1 billion revolving credit facility due in 2031 and $500 million term loan A-1 due in 2031. The `2' recovery rating indicates our expectation for substantial recovery (70%-90%, rounded estimate: 80%) in the event of a default. At the same time, we assigned our `##' issue-level rating and `5' recovery rating to Teleflex's proposed $500 million senior unsecured notes due in 2032. The `5' recovery rating indicates our expectation for modest recovery (10%-30%; rounded estimate: 15%). The notes will rank pari passu with the company's other senior unsecured debt. Teleflex will use the net proceeds from the new credit facilities (which also include a $700 million term loan A-2 due 2028) and notes with cash on hand to refinance its senior secured credit facilities of about $1.55 billion and...
